- Breast
- Lung
- Hematologic Oncology
- Gastrointestinal
- Genitourinary
- General Oncology
- Sarcoma
- Skin
- Head & Neck
- Event
Playback speed
10 seconds
Risk Stratification and Treatment of CLL: If New Drugs Available, 17p / TP53 Should Be Tested at 1st-Line and Relapse/Refractory
By
Xth Eurasian Hematology-Oncology Congress
FEATURING
Robin Foa
By
Xth Eurasian Hematology-Oncology Congress
FEATURING
Robin Foa
241 views
December 20, 2019
Comments 0
Login to view comments.
Click here to Login
Hematologic Oncology